New Service Combines Powerful Technology with Medical and Scientific Expertise PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today at annual ACMG Clinical Genetics Meeting in Phoenix that it has launched clinical interpretation services as a part of its entire Next Generation Sequencing (NGS) service portfolio. The new service represents PierianDx’s continued […]

Share loan from Dr. Heikki Lanckriet guarantees government soft loans Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS, will guarantee soft loans from the Spanish government with 500,000 of his SYGNIS shares. The guarantee secures the EUR 1.9 […]

OAKLAND, Calif. & DANVERS, Mass. & PHOENIX– Fabric Genomics, a global computational genomics company, and Veritas Genetics, the global leader in genetic sequencing and interpretation, announced today at the ACMG Annual Clinical Genetics Meeting that they have entered into a technology partnership. The goal of the collaboration is to accelerate Veritas’ myGenome product for personal […]

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting (ANN ARBOR, Mich.) Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane […]

OAKLAND, Calif. & PHOENIX Omicia today announced that it has rebranded and renamed the organization to better reflect the company’s ability to uniquely deliver clinical quality genomic data insights. Now known as Fabric Genomics TM, the company revealed its new name, logo and brand identity at this week’s ACMG Annual Clinical Genetics Meeting. The company […]

New product protects against intracellular immune responses and exonuclease attack Redwood City, California – Synthego, a leading provider of genome engineering solutions, today announces the availability of chemically modified synthetic guide RNA in the CRISPRevolution product family, including modified full length 100-mer synthetic single guide RNA (sgRNA). Critical for editing challenging cell types such as primary and […]

CarrierScan™ Assay from Thermo Fisher Scientific consolidates conventional multi-assay approach for “all-in-one” research  CARLSBAD, Calif. & PHOENIX–A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides molecular genetics laboratories with a consolidated and automated, single pan-ethnic solution for expanded carrier status research. Thermo Fisher Scientific announced […]

New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the product. This is […]

Advanced Analytical Technologies, Inc. (AATI) is excited to announce the release of myFRAG Online, your companion to the AATI family of instruments.  Sign-up for a free account and register your instrument(s) to have important resources at your fingertips, from User Manuals and Ladder Profiles, to Safety Data Sheets and PROSize® Data Analysis Software updates.  To […]

HUNTSVILLE, Ala.–Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing (NGS)-based assays, today announced it has entered into a co-marketing agreement with Illumina, Inc. (NASDAQ: ILMN). Under the terms of the agreement, Illumina will market and promote the Kailos TargetRich™ line of research solutions for pharmacogenetics targets through its […]